Ranked #1 Children's Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
Support the hospital with a donation that helps kids get the care they need.
A 13-year-old male presented to Boston Children’s Hospital Sports Medicine Division with complaints of right distal thigh and knee pain. He awoke the morning after a basketball game with significant discomfort and was unable to walk, suggesting an injury sustained during the game. A physical exam revealed exquisite tenderness of the distal quadriceps muscles, and the patient was unable to adequately fire his quadriceps muscle or extend his knee. Radiographs were normal.
The sports medicine physician referred the patient to Boston Children’s Radiology Department for an MRI of the knee to evaluate the quadriceps tendon. The same-day exam was performed at Boston Children’s ambulatory MRI.
Initial sequences through the knee revealed an obvious lesion in the quadriceps muscles. The lesion extended off of the superior aspect of the images and could not be completely assessed within the field of view.
After repositioning the patient in the MRI and using a larger coil capable of imaging the entire femur, the radiologist determined that the lesion in the muscle extended the entire length of the vastus intermedius muscle from the hip to the knee. Given strong concerns for a vascular anomaly, a dynamic contrast-enhanced MR angiogram was performed.
Based on the MRI findings, the patient was diagnosed with a fibroadipose vascular anomaly (FAVA), a rare vascular tumor of muscle, and referred to Boston Children’s Vascular Anomalies Center. He was evaluated by a multidisciplinary team consisting of surgeons, hematologists and an interventional radiologist, and will undergo sclerotherapy of the lesion, in addition to medical management for thrombophlebitis.
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”